Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors
University of California, San Francisco
University of California, San Francisco
Mayo Clinic
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Jonsson Comprehensive Cancer Center
Mayo Clinic
RenJi Hospital
Jonsson Comprehensive Cancer Center
Institut Claudius Regaud
NuCana plc
University of Virginia
UNICANCER
SOLTI Breast Cancer Research Group
Universitair Ziekenhuis Brussel
University of Florida
Northwestern University
Herlev Hospital
Ludwig Institute for Cancer Research
Duke University
Kantonsspital Winterthur KSW
University of Texas Southwestern Medical Center